Tetsuro Sasada Selected Research

HLA-A*33 antigen

4/2007	New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.
4/2004	Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuro Sasada Research Topics

Disease

72	Neoplasms (Cancer) 01/2022 - 09/2003
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2007
11	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 12/2010
10	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 07/2007
5	Melanoma (Melanoma, Malignant) 07/2017 - 05/2011
5	Leukemia 09/2013 - 02/2002
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2009
3	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 12/2014
3	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2004
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2017 - 03/2012
3	Adenocarcinoma 02/2008 - 04/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2018 - 01/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2017 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 01/2015
2	Hypersensitivity (Allergy) 07/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 07/2014 - 02/2008
2	Experimental Melanoma 04/2014 - 05/2011
2	Human Influenza (Influenza) 10/2012 - 06/2011
2	Stomach Neoplasms (Stomach Cancer) 06/2004 - 04/2004
1	Esophageal Neoplasms (Esophageal Cancer) 10/2019
1	Fibrosis (Cirrhosis) 07/2019
1	Hypersplenism (Anemia, Splenic) 07/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 09/2018
1	Carcinoma (Carcinomatosis) 12/2017
1	Papillomavirus Infections 04/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2016
1	Disease Progression 01/2016
1	Glioma (Gliomas) 01/2016

Drug/Important Bio-Agent (IBA)

48	Peptides (Polypeptides)IBA 02/2021 - 04/2004
31	AntigensIBA 01/2022 - 10/2004
15	Cancer VaccinesIBA 05/2020 - 04/2007
15	Protein Subunit VaccinesIBA 10/2019 - 04/2007
14	VaccinesIBA 01/2019 - 04/2007
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2010
9	EpitopesIBA 01/2019 - 04/2004
7	Immunoglobulin G (IgG)IBA 10/2015 - 07/2007
6	Messenger RNA (mRNA)IBA 10/2021 - 04/2004
5	Immune Checkpoint InhibitorsIBA 01/2022 - 05/2013
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 04/2007
4	Docetaxel (Taxotere)FDA Link 05/2020 - 08/2009
4	AntibodiesIBA 01/2020 - 07/2007
4	CytokinesIBA 10/2019 - 09/2013
4	PlatinumIBA 12/2017 - 09/2007
3	Therapeutic UsesIBA 01/2022 - 06/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2011
3	LigandsIBA 11/2017 - 08/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2013
3	Biological ProductsIBA 01/2016 - 09/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2013 - 05/2008
3	Cisplatin (Platino)FDA LinkGeneric 08/2009 - 06/2004
2	Immune Checkpoint ProteinsIBA 09/2018 - 01/2016
2	HLA-A Antigens (HLA-A)IBA 07/2018 - 06/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017 - 02/2016
2	HaptoglobinsIBA 12/2015 - 01/2013
2	Gefitinib (Iressa)FDA Link 01/2014 - 01/2013
2	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2013
2	HLA-A*02:01 antigenIBA 11/2013 - 06/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2013 - 09/2009
2	TubulinIBA 08/2009 - 06/2009
2	Fluorouracil (Carac)FDA LinkGeneric 02/2008 - 06/2004
2	Monomeric GTP-Binding ProteinsIBA 04/2007 - 10/2004
2	HLA-A*33 antigenIBA 04/2007 - 04/2004
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2021
1	Gemcitabine FDA Link 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	C-Reactive ProteinIBA 01/2020
1	NivolumabIBA 01/2020
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2019
1	N 30IBA 01/2019
1	MesothelinIBA 07/2018
1	Sorafenib (BAY 43-9006)FDA Link 09/2017
1	Galactosylceramides (Galactocerebrosides)IBA 07/2017
1	Blocking AntibodiesIBA 01/2016
1	B7-H1 AntigenIBA 01/2016
1	HLA-A*26 antigenIBA 10/2015
1	ArginaseIBA 01/2015

Therapy/Procedure

25	Immunotherapy 01/2020 - 04/2004
18	Drug Therapy (Chemotherapy) 01/2020 - 06/2004
11	Therapeutics 01/2022 - 08/2009
10	Castration 05/2020 - 12/2010
7	Aftercare (After-Treatment) 10/2021 - 06/2012
2	Splenectomy 07/2019 - 05/2008
2	Immunomodulation 01/2016 - 09/2003
2	Hematopoietic Stem Cell Transplantation 09/2013 - 09/2009
1	Radiotherapy 01/2020
1	Neoadjuvant Therapy 11/2017
1	Adjuvant Chemotherapy 09/2017
1	Craniotomy 01/2016